Optilume® is an innovative drug-coated balloon designed for the treatment of recurrent urethral strictures. It combines balloon dilation with local delivery of paclitaxel, which helps reduce scar formation and lowers the risk of stricture recurrence.
Clinical studies have demonstrated superior outcomes compared with standard dilation or DVIU, with approximately 78% of patients remaining free from recurrence at 2 years and over 70% avoiding repeat intervention at 5 years. Patients also experience significant improvements in urinary flow and symptoms, with a favorable safety profile and no significant impact on erectile function.
Optilume® offers an effective minimally invasive option for selected patients with recurrent urethral stricture disease and may delay or avoid the need for urethroplasty.
